Indegene
INDGN · > Business Support Listing date: May 13, 2024

Stock Price vs Company Growth
1d
0.2%
1w
6.1%
1m
9.8%
3m
7.9%
6m
1.3%
1y
2.6%
all
3.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 530 0.2%
415
554
Company Overview

Sales
3,510 Cr
Growth: 17.8%
Profit after Tax
401 Cr
Growth: -8.6%
Mid Cap
12,773 Cr
P/E: 31.9x
Industry P/E: 28.2x
Fundamentals

Sales (Cr) ₹ 3,510
Growth 17.8%
EBITDA 17.6%
P/S 3.6x
Dividend 0.3%
P/E 31.9x
Book Value ₹ 130
PEG Ratio 1.8x
ROE 13.8%
P/B 4.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company offers solutions straddling the different stages of the commercialization lifecycle of drugs and medical devices. It caters to the commercial function needs of life sciences companies through its Enterprise Commercial Solutions and its Omnichannel Activation Solutions. For the medical and R&D function needs, it operates through its Enterprise Medical Solutions and Enterprise Clinical Solutions.
Investors (4)
Followers (1)